Express delivery and free returns within 21 days

Wednesday, July 6, 2022

MEDICAL DEVICE NEWS MAGAZINE

|

Contact us 561.316.3330

Medical Device Company Lazurite™ to Relocate its Headquarters to Accommodate Growth

Medical device and technology company Lazurite Holdings LLC announced today the relocation and expansion of its headquarters from Cleveland to a new office space in suburban Warrensville Heights, Ohio, to advance the operations and growth of the company. The new office space is located at 4700 Richmond Road.

“We are thrilled to relocate our headquarters to Warrensville Heights as the area will provide the foundation for our continued growth initiatives going forward,” said Leah Brownlee, President. “We selected Warrensville Heights because of its attractive economic development incentive program, convenient location, and because the space already had the electronic labs set up that we require, not to mention it lives up to being a ‘Friendly City.’”

Raymon Turner, Community Development Manager for the city stated, “We are extremely pleased to welcome Lazurite Holdings LLC to our city. They are on the cutting edge of medical technology with the creation of their fully wireless, minimally invasive camera system platform. With our close proximity to both University Hospitals and the Cleveland Clinic we see this as a wonderful opportunity to bolster the medical research and training happening right now in our community.”

Expanding to 6,000 square feet from its current 3,000 square feet will provide the necessary infrastructure for the company to continue to build on its current momentum. Lazurite currently employs 15 people and plans to onboard at least 10 employees in 2022 primarily in research and development and sales roles.

Earlier this year, Lazurite’s ArthroFree™ Wireless Surgical Camera won the prestigious inaugural ACE Award for Innovation from the American Orthopaedic Society for Sports Medicine. The company is taking steady steps on its plan to launch its ArthroFree wireless arthroscopic camera system next year. Lazurite plans to submit its premarket notification this year and expects to receive FDA approval to launch in the first half of 2022.

The ArthroFree™ wireless arthroscopic camera system has not yet received FDA clearance and is not currently approved for human use. It is not intended for commercial distribution; orders cannot be accepted at this time.

 

SourceLazurite

By using this website you agree to accept Medical Device News Magazine Privacy Policy